Navigation Links
New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy
Date:9/18/2007

h Products, L.P. In the European Union, Russia, Switzerland and other countries, PREZISTA is marketed by Tibotec, a division of Janssen-Cilag. In Canada, PREZISTA is marketed by Tibotec, a division of Janssen-Ortho Inc. Applications for approval of PREZISTA also have been submitted or are planned for submission in many other countries.

About Tibotec Therapeutics

Tibotec Therapeutics, a division of Ortho Biotech Products, L.P., headquartered in Bridgewater, N.J., is dedicated to delivering innovative virology therapeutics that help healthcare professionals address serious unmet needs in people living with HIV.

About Tibotec Pharmaceuticals Ltd.

Tibotec Pharmaceuticals Ltd., based in Cork, Ireland, is a pharmaceutical research and development company. The Company's main research and development facilities are in Mechelen, Belgium with offices in Yardley, PA. Tibotec is dedicated to the discovery and development of innovative HIV/AIDS drugs and anti-infectives for diseases of high unmet medical need.

Tibotec Pharmaceuticals is developing a Global Access Program to facilitate access to its antiretrovirals for patients living with HIV/AIDS in developing countries. The Global Access Program for PREZISTA includes access pricing, registration, medical education for appropriate use and voluntary licensing.

This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from the Company's expectations and projections. Risks and uncertainties include general industry conditions and competition; economic conditions, such as interest rate and currency exchange rate fluctuations; technological advances and patents attained by competitors; challenges inherent in new product development, includ
'/>"/>

SOURCE Tibotec Therapeutics
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
7. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
8. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
9. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
10. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... 2015 ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) today ... ended December 31, 2014 on March 9, 2015. The Company also ... Thursday, March 12, 2015, at 5:00 pm ET. The call will ...   , , , LIVE CALL:  , ... 92238648. , , , , ...
(Date:3/1/2015)... , March 1, 2015 /CNW Telbec/ -   Ergoresearch Ltd ... and known under the « Équilibre, ... the second quarter Ended on December 31, 2014. All ... currency. Revenues for the second quarter ... 2014 totaled $ 4 095 112 decreasing by 8,8 % compared to ...
(Date:3/1/2015)...  USPlabs has notified the Food and Drug ... media reports saying that a company product contains ... 28, 2015, the Center for Drug Evaluation and ... contamination of a dietary supplement product labeled as ... "OEP") with a prescription drug active ingredient, fluoxetine. ...
Breaking Medicine Technology:ImmunoCellular Therapeutics to Report 2014 Financial Results on March 9, 2015; a Business Update Conference Call and Webcast is Scheduled for March 12, 2015 2Second Quarter results - Fiscal 2015 - Ergoresearch reports its results for the quarter ended December 31, 2014. 2Second Quarter results - Fiscal 2015 - Ergoresearch reports its results for the quarter ended December 31, 2014. 3Second Quarter results - Fiscal 2015 - Ergoresearch reports its results for the quarter ended December 31, 2014. 4OEP Product Is Counterfeit 2
... TEL-AVIV, Israel , March 15, 2010 Cheetah Medical, a,worldwide leader in noninvasive hemodynamic and cardiac output ... and also included Robert,Bosch Venture Capital (RBVC), MVM Life Science Partners (MVM) and existing,investors. , ... ... ...
... With heart disease continuing to be the No. 1 cause of death in the U.S., Atherotech Inc. has ... company is expanding its disease management services with the goal of helping physicians reduce death and disability from heart disease. ... ... , ...
Cached Medicine Technology:Cheetah Medical Closes $20 Million Series B Financing 2Cheetah Medical Closes $20 Million Series B Financing 3Cheetah Medical Closes $20 Million Series B Financing 4Cheetah Medical Closes $20 Million Series B Financing 5Cheetah Medical Closes $20 Million Series B Financing 6Atherotech Recruits Top Experts in Fight Against Heart Disease 2Atherotech Recruits Top Experts in Fight Against Heart Disease 3Atherotech Recruits Top Experts in Fight Against Heart Disease 4Atherotech Recruits Top Experts in Fight Against Heart Disease 5Atherotech Recruits Top Experts in Fight Against Heart Disease 6
(Date:3/2/2015)... 2015 Regulatory Compliance Associates® Inc. ... regulatory and technical consulting, announces Mr. Seyed Khorashahi ... , Before joining RCA, Mr. Khorashahi had ... in all aspects of developing safety-critical medical devices. ... (Medtronic), Regulatory Compliance Associates Inc., Baxter Healthcare, and ...
(Date:3/2/2015)... The Alliance for Bangladesh Worker Safety today ... to serve as chief safety officer. In this role, ... Bangladesh and guide remediation efforts in all factories from ... that the Alliance continues to bring world-class expertise to ... workers,” said Alliance Independent Chair Ellen Tauscher. “His role ...
(Date:3/2/2015)... Final Cut Pro X plugin specialists ... Pixel Film Studios. , “The TranStatic Volume 2 plugin gives ... Austin, CEO of Pixel Film Studios. “TranStatic Volume 2 is ... X editors toolbox.” , With TranStatic Volume 2 users can ... static scrambling effects from Pixel Film Studios. Users have total ...
(Date:3/1/2015)... (PRWEB) March 02, 2015 As ... web works co-founders, Michael Burns and Carita Weaver, ... addition to working with the Southlake Chamber of ... i5 web works recently launched a website for ... , A primary communications tool for Hill’s campaign, ...
(Date:3/1/2015)... Adults who are not legally married ... or universal policies can now use the QuotesPros.com portal ... insurance companies for single adults can now be researched ... . , The rate plans that nationwide agencies are ... a number of life protection policies. The term, universal ...
Breaking Medicine News(10 mins):Health News:Regulatory Compliance Associates® Inc. Welcomes Seyed Khorashahi as Chief Operating Officer 2Health News:Alliance for Bangladesh Worker Safety Names New Chief Safety Officer 2Health News:Pixel Film Studios released the TranStatic Volume 2 plugin for Final Cut Pro X today 2Health News:Website Launched for Southlake, Texas Mayoral Candidate Laura Hill 2Health News:Best Life Insurance Companies for Single Adults Now Searchable at Insurance Website 2
... identified in the blood of chronic sinusitis sufferers that ... disease, researchers say. , They used a sophisticated research ... proteins and found among 96 chronic sinusitis patients a ... can diagnose this disease with a totally objective test ...
... will support nonprofit organizations that address health care ... access and priorities in a four-state ... Group, the largest,health insurer in the Northwest/ Intermountain region, ... transforming health care in,the United States. The Regence Foundation ...
... who,has served as chairman and CEO of global safety ... Bill Lambert, MSA president and chief operating,officer, will ring ... on,Tuesday, April 15. The ceremonial bell ringing comes approximately ... as part of a planned management,succession, and turn over ...
... ,Pet Parent,s Day, e-Cards available on petinsurance.com, ... (VPI),the nation,s oldest and largest provider of pet ... -- this year, April 27 -- as National,Pet ... celebrating pet,caregivers. In the traditional spirit of a ...
... cells drive breast cancer formation, researcher says , , MONDAY, ... suggest breast cancer may arise from stem cells and ... may be a key to treatment. , Researchers from ... gene can flip open two known cancer pathways in ...
... at Thomas Jefferson University in Philadelphia are inching ... might help prevent the spread of pancreatic cancer. ... type of pressure-lowering drug called an angiotensin receptor ... cell death. , In earlier work in the ...
Cached Medicine News:Health News:Potential blood test for chronic sinusitis identified 2Health News:Newly Launched Regence Foundation to Help Transform Health Care and Influence the Nationwide Health Care Debate 2Health News:MSA's John Ryan III and Bill Lambert to Ring Closing Bell at New York Stock Exchange on Tuesday 2Health News:MSA's John Ryan III and Bill Lambert to Ring Closing Bell at New York Stock Exchange on Tuesday 3Health News:Veterinary Pet Insurance Launches National Pet Parent's Day 2Health News:Stem Cell Marker Controls Pair of Key Cancer Pathways 2Health News:Blood pressure drugs halt pancreatic cancer cell growth, Jefferson researchers find 2
The S4 Spinal System has quickly gained a reputation for being the next generation in pedicle screw systems because of its exceptionally small size and high biomechanical strength....
... Diagnostics is a clinical reference ... treatment and monitoring of hemostatic ... a collaboration of four laboratory ... defined vision to deliver customizable ...
All-natural porcine collagen can be used in open or laparoscopic placement....
...
Medicine Products: